← Leaderboards
Christoph Buettner
Icahn School Of Medicine At Mount Sinai
$9,918,421
Attributed
$14,552,546
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,552,546 · 12
By mechanism
R01$12,418,857 · 5
P50$1,202,199 · 1
K08$509,874 · 1
R03$168,653 · 1
R56$127,125 · 1
P41$125,838 · 3
Top collaborators
- Mariana Gross Figueiro6 shared
- Alessandro Bartolomucci5 shared
- Stephen R Salton5 shared
- Shaohua Li3 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Stephen R Salton$16,387,402
- Michele A La Merrill$2,807,938
- Jeremy Seth Leventhal$1,179,095
- Minghui Wang$1,519,632
Others in their field
Top investigators on “Insulin”
- Jeffrey P Krischer · University Of South Florida$605,714,892
- John M Lachin · George Washington University$153,440,346
- David M Nathan · Massachusetts Institute Of Technology$139,041,931
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Mark A Magnuson · Vanderbilt University$79,749,111
- Jose A Luchsinger · Columbia University Health Sciences$71,267,462
Research focus
InsulinMetabolismPathway InteractionsBrainNon-Insulin-Dependent Diabetes MellitusGlucoseInsulin ResistanceHomeostasisPeripheralAdipose TissueRegulationHypothalamic StructureObesityMolecularNeuronsSignal TransductionLipid MetabolismInsulin SignalingLipolysisLipidsMetabolicMouse ModelLiverBase
Grant awards (42)
Role of CREG1 in metabolic homeostasis$443,293
R01 · FY2025 · DK
Role of CREG1 in metabolic homeostasis$472,845
R01 · FY2024 · DK
Light, metabolic syndrome and Alzheimer's disease: a non-pharmacological approach$915,187
R01 · FY2023 · AG
Role of CREG1 in metabolic homeostasis$492,547
R01 · FY2023 · DK
Light, metabolic syndrome and Alzheimer's disease: a non-pharmacological approach$937,999
R01 · FY2021 · AG
Neural mechanisms for VGF regulation of energy balance$556,723
R01 · FY2021 · DK
Neural mechanisms for VGF regulation of energy balance$556,723
R01 · FY2020 · DK
Light, metabolic syndrome and Alzheimer's disease: a non-pharmacological approach$486,938
R01 · FY2020 · AG
Neural mechanisms for VGF regulation of energy balance$421,632
R01 · FY2020 · DK
Light, metabolic syndrome and Alzheimerâs disease: a non-pharmacological approach$320,900
R01 · FY2020 · AG
Light, metabolic syndrome and Alzheimerâs disease: a non-pharmacological approach$804,753
R01 · FY2019 · AG
Neural mechanisms for VGF regulation of energy balance$556,723
R01 · FY2019 · DK
Project 2: Insulin signaling and action in the Alzheimer brain and in iPSC-derived human brain cells$261,942
P50 · FY2019 · AG · contact PI
Light, metabolic syndrome and Alzheimerâs disease: a non-pharmacological approach$839,256
R01 · FY2018 · AG
Neural mechanisms for VGF regulation of energy balance$574,098
R01 · FY2018 · DK
A Role of Hypothalamic Dysfunction in Alcoholic Liver Disease$381,375
R01 · FY2018 · AA · contact PI
Project 2: Insulin signaling and action in the Alzheimer brain and in iPSC-derived human brain cells$256,839
P50 · FY2018 · AG · contact PI
A Role of Hypothalamic Dysfunction in Alcoholic Liver Disease$381,375
R01 · FY2017 · AA · contact PI
Project 2: Insulin signaling and action in the Alzheimer brain and in iPSC-derived human brain cells$222,303
P50 · FY2017 · AG · contact PI
A Role of Hypothalamic Dysfunction in Alcoholic Liver Disease$17,998
R01 · FY2017 · AA · contact PI
A Role of Hypothalamic Dysfunction in Alcoholic Liver Disease$476,719
R01 · FY2016 · AA · contact PI
Project 2: Insulin signaling and action in the Alzheimer brain and in iPSC-derived human brain cells$221,435
P50 · FY2016 · AG · contact PI
Regulation of Adipose Tissue Metabolism by Central Insulin and Leptin$127,125
R56 · FY2016 · DK · contact PI
A Role of Hypothalamic Dysfunction in Alcoholic Liver Disease$462,416
R01 · FY2015 · AA · contact PI
Project 2: Insulin signaling and action in the Alzheimer brain and in iPSC-derived human brain cells$239,680
P50 · FY2015 · AG · contact PI
A Role of Hypothalamic Dysfunction in Alcoholic Liver Disease$381,375
R01 · FY2014 · AA · contact PI
A Role of Hypothalamic Dysfunction in Alcoholic Liver Disease$55,616
R01 · FY2014 · AA · contact PI
Regulation of adipose tissue metabolism by central insulin and leptin$348,680
R01 · FY2013 · DK · contact PI
Regulation of Adipose Tissue Metabolism by Central Insulin and Leptin$1,500
R01 · FY2013 · DK · contact PI
Regulation of adipose tissue metabolism by central insulin and leptin$361,327
R01 · FY2012 · DK · contact PI
Regulation of adipose tissue metabolism by central insulin and leptin$361,327
R01 · FY2011 · DK · contact PI
PROTEOMIC STUDY OF HEPATIC METABOLISM REGULATED BY HYPOTHALAMIC PATHWAYS$28,669
P41 · FY2011 · RR · contact PI
Regulation of adipose tissue metabolism by central insulin and leptin$402,732
R01 · FY2010 · DK · contact PI
The role of the endocannabinoid system in regulating hepatic glucose fluxes$83,903
R03 · FY2010 · DK · contact PI
PROTEOMIC STUDY OF HEPATIC METABOLISM REGULATED BY HYPOTHALAMIC PATHWAYS$32,124
P41 · FY2010 · RR · contact PI
Regulation of adipose tissue metabolism by central insulin and leptin$406,800
R01 · FY2009 · DK · contact PI
The role of Stat3 signaling in leptin's pleitropic action$116,754
K08 · FY2009 · DK · contact PI
The role of the endocannabinoid system in regulating hepatic glucose fluxes$84,750
R03 · FY2009 · DK · contact PI
PROTEOMIC STUDY OF HEPATIC METABOLISM REGULATED BY HYPOTHALAMIC PATHWAYS$65,045
P41 · FY2009 · RR · contact PI
The role of Stat3 signaling in leptin's pleitropic action$130,545
K08 · FY2008 · DK · contact PI
The role of Stat3 signaling in leptin's pleitropic action$129,465
K08 · FY2007 · DK · contact PI
The role of Stat3 signaling in leptin's pleitropic action.$133,110
K08 · FY2006 · DK · contact PI